Published in Stud Health Technol Inform on January 01, 2007
Automated information extraction of key trial design elements from clinical trial publications. AMIA Annu Symp Proc (2008) 1.93
Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics (2010) 1.88
Sentence retrieval for abstracts of randomized controlled trials. BMC Med Inform Decis Mak (2009) 1.50
Systematic identification of pharmacogenomics information from clinical trials. J Biomed Inform (2012) 1.03
The Ontology of Clinical Research (OCRe): an informatics foundation for the science of clinical research. J Biomed Inform (2013) 1.01
Automating data extraction in systematic reviews: a systematic review. Syst Rev (2015) 0.95
Extracting Characteristics of the Study Subjects from Full-Text Articles. AMIA Annu Symp Proc (2015) 0.75
Why Health Services Research Needs Geoinformatics: Rationale and Case Example. J Health Med Inform (2014) 0.75
Towards Evidence-based Precision Medicine: Extracting Population Information from Biomedical Text using Binary Classifiers and Syntactic Patterns. AMIA Jt Summits Transl Sci Proc (2016) 0.75
Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science (2008) 8.52
The incidentalome: a threat to genomic medicine. JAMA (2006) 7.24
Genetics. Genomic research and human subject privacy. Science (2004) 6.56
PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res (2002) 6.40
A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae). Proc Natl Acad Sci U S A (2003) 6.19
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med (2010) 5.14
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med (2010) 4.16
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource. Biomark Med (2011) 4.05
Knowledge acquisition, consistency checking and concurrency control for Gene Ontology (GO). Bioinformatics (2003) 3.97
SAFA: semi-automated footprinting analysis software for high-throughput quantification of nucleic acid footprinting experiments. RNA (2005) 3.95
Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85
Associating genes with gene ontology codes using a maximum entropy analysis of biomedical literature. Genome Res (2002) 3.77
Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics (2002) 3.65
Health-information altruists--a potentially critical resource. N Engl J Med (2005) 3.61
The RNA Ontology Consortium: an open invitation to the RNA community. RNA (2006) 3.60
Creating an online dictionary of abbreviations from MEDLINE. J Am Med Inform Assoc (2002) 3.32
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20
Data-driven prediction of drug effects and interactions. Sci Transl Med (2012) 2.93
Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92
Modeling electronic discharge summaries as a simple temporal constraint satisfaction problem. J Am Med Inform Assoc (2004) 2.88
Eukaryotic regulatory element conservation analysis and identification using comparative genomics. Genome Res (2004) 2.84
Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res (2004) 2.83
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med (2014) 2.69
Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. JAMA (2013) 2.68
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet (2007) 2.65
Coarse-grained modeling of large RNA molecules with knowledge-based potentials and structural filters. RNA (2009) 2.63
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA (2006) 2.53
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J Am Med Inform Assoc (2011) 2.53
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. Lancet Oncol (2010) 2.52
The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res (2007) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Bioinformatics challenges for personalized medicine. Bioinformatics (2011) 2.28
Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care (2005) 2.26
Time to organize the bioinformatics resourceome. PLoS Comput Biol (2005) 2.25
MScanner: a classifier for retrieving Medline citations. BMC Bioinformatics (2008) 2.24
Using binning to maintain confidentiality of medical data. Proc AMIA Symp (2002) 2.23
Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc (2013) 2.19
Using text to build semantic networks for pharmacogenomics. J Biomed Inform (2010) 2.19
Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med (2007) 2.16
Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics (2009) 2.15
PharmGKB: understanding the effects of individual genetic variants. Drug Metab Rev (2008) 2.09
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. J Clin Oncol (2007) 2.09
Influence of race on inpatient treatment intensity at the end of life. J Gen Intern Med (2007) 2.07
Ontology-based annotation and query of tissue microarray data. AMIA Annu Symp Proc (2006) 2.05
GAPSCORE: finding gene and protein names one word at a time. Bioinformatics (2004) 2.05
Dynamic reconfiguration of structural and functional connectivity across core neurocognitive brain networks with development. J Neurosci (2011) 2.00
Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol (2005) 1.98
Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96
Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood) (2005) 1.95
Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res (2004) 1.92
Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics (2010) 1.91
A menu without prices. Ann Intern Med (2008) 1.89
Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics (2010) 1.88
Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML. Pac Symp Biocomput (2002) 1.81
PharmGKB: the Pharmacogenomics Knowledge Base. Methods Mol Biol (2013) 1.81
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol (2005) 1.80
Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med (2008) 1.78
High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis. Nucleic Acids Res (2008) 1.78
Using text analysis to identify functionally coherent gene groups. Genome Res (2002) 1.71
Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract (2005) 1.69
Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax. Ann Intern Med (2005) 1.69
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med (2009) 1.68
Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.68
The FEATURE framework for protein function annotation: modeling new functions, improving performance, and extending to novel applications. BMC Genomics (2008) 1.64
Essential elements of a technology and outcomes assessment initiative. JAMA (2007) 1.63
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med (2003) 1.63
Finding haplotype tagging SNPs by use of principal components analysis. Am J Hum Genet (2004) 1.61
MutDB: annotating human variation with functionally relevant data. Bioinformatics (2003) 1.54
Structural inference of native and partially folded RNA by high-throughput contact mapping. Proc Natl Acad Sci U S A (2008) 1.54
Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics (2011) 1.53
Training the next generation of informaticians: the impact of "BISTI" and bioinformatics--a report from the American College of Medical Informatics. J Am Med Inform Assoc (2004) 1.53
Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomput (2012) 1.53
Geographic variation in Medicare services. N Engl J Med (2013) 1.51
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation (2003) 1.45
The computational analysis of scientific literature to define and recognize gene expression clusters. Nucleic Acids Res (2003) 1.44
Training synergies between medical informatics and health services research: successes and challenges. J Am Med Inform Assoc (2002) 1.42
Independent component analysis: mining microarray data for fundamental human gene expression modules. J Biomed Inform (2010) 1.39
Local kinetic measures of macromolecular structure reveal partitioning among multiple parallel pathways from the earliest steps in the folding of a large RNA molecule. J Mol Biol (2006) 1.38
Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics (2012) 1.38
Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. J Clin Epidemiol (2008) 1.37
The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care (2006) 1.37
A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge. J Am Med Inform Assoc (2004) 1.37
WebFEATURE: An interactive web tool for identifying and visualizing functional sites on macromolecular structures. Nucleic Acids Res (2003) 1.35
A literature-based method for assessing the functional coherence of a gene group. Bioinformatics (2003) 1.33
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med (2009) 1.33
A call for the creation of personalized medicine databases. Nat Rev Drug Discov (2006) 1.30
Extracting and characterizing gene-drug relationships from the literature. Pharmacogenetics (2004) 1.30
Using ODIN for a PharmGKB revalidation experiment. Database (Oxford) (2012) 1.29
Integration and publication of heterogeneous text-mined relationships on the Semantic Web. J Biomed Semantics (2011) 1.29
Biomedical term mapping databases. Nucleic Acids Res (2005) 1.29
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics (2011) 1.29